Comprehensive Clinical Development, Inc.

Cerritos, California 90703

0 studies enrolling now · 6 studies all time

What they study most

Generalized Anxiety Disorder, Schizophrenia

Studies at this site

• A Twelve Week, Open Label Extension Study in Patients With Schizophrenia — Completed
• A Study to Investigate the Efficacy, Safety and Tolerability of Four Different Doses of BI 409306 Compared to Placebo Given for 12 Weeks in Patients With Schizophrenia on Stable Antipsychotic Treatment. — Completed
• POC Study in Partially Responsive Generalized Anxiety Disorder — Stopped early
• An Outpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Adjunctive Treatment Of Sub-Optimally Controlled Symptoms of Schizophrenia — Stopped early
• PEARL Schizophrenia Maintenance — Completed
• An Open Label Study of Aripiprazole Intramuscular Injection in Subjects With Schizophrenia — Completed